PRESS RELEASE published on 11/20/2025 at 15:51, 6 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.67% stake in Qualcomm Incorporated as of 19 November 2025. Purchase and sale of USD 0.0001 common shares The Vanguard Group Stake Disclosure Stock Transactions Investment Disclosure Qualcomm Incorporated
BRIEF published on 11/20/2025 at 15:50, 6 months 17 days ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Vanguard Group Shareholding Irish Takeover Mural Oncology
PRESS RELEASE published on 11/20/2025 at 15:50, 6 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as per Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure American Axle
BRIEF published on 11/20/2025 at 15:49, 6 months 17 days ago The Vanguard Group Discloses Position in Greencore Group Securities Disclosure Takeover Code Vanguard Group Greencore Group
PRESS RELEASE published on 11/20/2025 at 15:48, 6 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% position in JTC plc's 1p ordinary securities as of 19 November 2025 Position Disclosure The Vanguard Group 1p Ordinary Securities 5.05% JTC Plc
BRIEF published on 11/20/2025 at 15:48, 6 months 17 days ago Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 Takeover Code Securities Disclosure Vanguard Group Bluefield Solar
PRESS RELEASE published on 11/20/2025 at 15:46, 6 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group discloses a 5.71% stake in Avadel Pharmaceuticals plc. Form 8.3 submitted to the Irish Takeover Panel on 20-Nov-2025 Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 11/20/2025 at 15:46, 6 months 17 days ago The Vanguard Group Discloses Interests in Spire Healthcare Form 8.3 Takeover Code Spire Healthcare Shareholding Vanguard
PRESS RELEASE published on 11/20/2025 at 15:45, 6 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc as per Form 8.3 to the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
BRIEF published on 11/20/2025 at 15:45, 6 months 17 days ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group Plc
Published on 06/06/2026 at 04:45, 2 days 2 hours ago Battery X Metals Announces Closing of First Tranche of Private Placement to Advance Corporate Growth
Published on 06/06/2026 at 00:00, 2 days 7 hours ago Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 2 days 14 hours ago Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 2 days 16 hours ago Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 2 days 17 hours ago CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/08/2026 at 06:30, 31 minutes ago Business update: Kardex adjusts its EBIT forecast for 2026
Published on 06/08/2026 at 06:10, 51 minutes ago Camel Energy GmbH Showcases Advanced Battery Technologies at AABC Europe 2026
Published on 06/08/2026 at 06:02, 59 minutes ago Rumble Announces Final Results of Exchange Offer for Northern Data
Published on 06/08/2026 at 05:20, 1 hour 41 minutes ago Sensing Meets Connectivity: Calterah Launches Ultra-Powerful mmWave Radar Chips for High-Performance ADAS and Leading-Edge UWB Radar Solutions
Published on 06/07/2026 at 21:24, 9 hours 37 minutes ago EQS-Adhoc: Readcrest Capital AG: Management Board issues forecast for adjusted EBITDA in 2026
Published on 06/05/2026 at 14:50, 2 days 16 hours ago Guillemot Corporation | Information regarding the total number of voting rights and shares 31/05/2026
Published on 06/04/2026 at 20:00, 3 days 11 hours ago Schneider Electric announces the reference share price the initial conversion/exchange ratio of its €850 million new bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2034 and the results of the repurchase of the OC
Published on 06/04/2026 at 18:23, 3 days 12 hours ago Shareholders’ Meeting and board of directors’ meeting held on June 4, 2026
Published on 06/04/2026 at 18:00, 3 days 13 hours ago Information concerning the total number of voting rights and shares in the share capital as of May 29, 2026
